Chapter 59. Hypertension, Cardiovascular Disease, and Lipid Abnormalities in Children with Chronic Kidney Failure

  1. Donald A. Molony MD2,3 and
  2. Jonathan C. Craig MD, PhD4,5
  1. Elke Wühl MD and
  2. Franz Schaefer

Published Online: 4 MAR 2009

DOI: 10.1002/9781444303391.ch59

Evidence-Based Nephrology

Evidence-Based Nephrology

How to Cite

Wühl, E. and Schaefer, F. (2008) Hypertension, Cardiovascular Disease, and Lipid Abnormalities in Children with Chronic Kidney Failure, in Evidence-Based Nephrology (eds D. A. Molony and J. C. Craig), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303391.ch59

Editor Information

  1. 2

    Division of Renal Disease and Hypertension, University of Texas, USA

  2. 3

    Houston Medical School, Houston, Texas, USA

  3. 4

    School of Public Health, University of Sydney, Australia

  4. 5

    Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia

Author Information

  1. Division of Pediatric Nephrology, Center for Pediatric and Adolescent Medicine, University of Heidelberg, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany

Publication History

  1. Published Online: 4 MAR 2009
  2. Published Print: 5 DEC 2008

ISBN Information

Print ISBN: 9781405139755

Online ISBN: 9781444303391

SEARCH

Keywords:

  • chronic kidney disease (CKD);
  • measurement of BP in children and selection of appropriate normative data;
  • efficacies of strategies for treatment of hypertension in children;
  • CVD in children with CKF;
  • efficacies of strategies for prevention of CVD in children;
  • lipid abnormalities in pediatric kidney disease;
  • efficacies of strategies for prevention and treatment of lipid abnormalities in children

Summary

This chapter contains sections titled:

  • Introduction

  • Hypertension

  • Measurement of BP in children and selection of appropriate normative data

  • Efficacies of strategies for prevention and treatment of hypertension in children

  • CVD in children with CKF

  • Efficacies of strategies for prevention of CVD in children

  • Lipid abnormalities in pediatric kidney disease

  • Efficacies of strategies for prevention and treatment of lipid abnormalities in children

  • Conclusions

  • References